BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 12717216)

  • 41. Sirolimus does not increase the risk for postoperative thromboembolic events among renal transplant recipients.
    Langer RM; Kahan BD
    Transplantation; 2003 Jul; 76(2):318-23. PubMed ID: 12883185
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Human allograft arterial injury is ameliorated by sirolimus and cyclosporine and correlates with suppression of interferon-gamma.
    Yi T; Cuchara L; Wang Y; Koh KP; Ranjbaran H; Tellides G; Pober JS; Lorber MI
    Transplantation; 2006 Feb; 81(4):559-66. PubMed ID: 16495804
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Limited sampling strategies for the estimation of sirolimus daily exposure in kidney transplant recipients on a calcineurin inhibitor-free regimen.
    Cattaneo D; Cortinovis M; Baldelli S; Gotti E; Remuzzi G; Perico N
    J Clin Pharmacol; 2009 Jul; 49(7):773-81. PubMed ID: 19491334
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
    Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
    Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Use of sirolimus to facilitate steroid withdrawal from a cyclosporine regimen.
    Kahan BD; Podbielski J; Schoenberg L
    Transplant Proc; 2006 Nov; 38(9):2842-6. PubMed ID: 17112844
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
    Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
    Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sirolimus therapy predisposes to new-onset diabetes mellitus after renal transplantation: a long-term analysis of various treatment regimens.
    Gyurus E; Kaposztas Z; Kahan BD
    Transplant Proc; 2011 Jun; 43(5):1583-92. PubMed ID: 21693238
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Development of a predictive limited sampling strategy for estimation of mycophenolic acid area under the concentration time curve in patients receiving concomitant sirolimus or cyclosporine.
    Figurski MJ; Nawrocki A; Pescovitz MD; Bouw R; Shaw LM
    Ther Drug Monit; 2008 Aug; 30(4):445-55. PubMed ID: 18641543
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Early sirolimus use with cyclosporine elimination does not induce progressive proteinuria.
    Ruiz JC; Campistol JM; Sanchez-Fructuoso A; Mota A; Grinyo JM; Paul J; Castro-Henriques A; Reimao-Pinto J; Garcia J; Morales JM; Granados E; Arias M
    Transplant Proc; 2007 Sep; 39(7):2151-2. PubMed ID: 17889121
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effects of gender and age on health-related quality of life following kidney transplantation.
    Liu H; Feurer ID; Dwyer K; Speroff T; Shaffer D; Wright Pinson C
    J Clin Nurs; 2008 Jan; 17(1):82-9. PubMed ID: 18088260
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunosuppressant use without bone loss--implications for bone loss after transplantation.
    Goodman GR; Dissanayake IR; Sodam BR; Gorodetsky E; Lu J; Ma YF; Jee WS; Epstein S
    J Bone Miner Res; 2001 Jan; 16(1):72-8. PubMed ID: 11149492
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-term benefits with sirolimus-based therapy after early cyclosporine withdrawal.
    Kreis H; Oberbauer R; Campistol JM; Mathew T; Daloze P; Schena FP; Burke JT; Brault Y; Gioud-Paquet M; Scarola JA; Neylan JF;
    J Am Soc Nephrol; 2004 Mar; 15(3):809-17. PubMed ID: 14978184
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of cyclosporine and sirolimus effects on serum creatinine level over five years after kidney transplantation.
    Soleimani AR; Kamkar I; Nikoueinejad H; Moraweji AR
    Transplant Proc; 2013 May; 45(4):1644-7. PubMed ID: 23726639
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Kidney function and morphology after short-term combination therapy with cyclosporine A, tacrolimus and sirolimus in the rat.
    Nielsen FT; Ottosen P; Starklint H; Dieperink H
    Nephrol Dial Transplant; 2003 Mar; 18(3):491-6. PubMed ID: 12584269
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sirolimus-based therapy following early cyclosporine withdrawal provides significantly improved renal histology and function at 3 years.
    Mota A; Arias M; Taskinen EI; Paavonen T; Brault Y; Legendre C; Claesson K; Castagneto M; Campistol JM; Hutchison B; Burke JT; Yilmaz S; Häyry P; Neylan JF;
    Am J Transplant; 2004 Jun; 4(6):953-61. PubMed ID: 15147430
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Drug interaction between cyclosporine and mTOR inhibitors in experimental model of chronic cyclosporine nephrotoxicity and pancreatic islet dysfunction.
    Piao SG; Bae SK; Lim SW; Song JH; Chung BH; Choi BS; Yang CW
    Transplantation; 2012 Feb; 93(4):383-9. PubMed ID: 22267156
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Five-year results of a randomized trial comparing de novo sirolimus and cyclosporine in renal transplantation: the SPIESSER study.
    Lebranchu Y; Snanoudj R; Toupance O; Weestel PF; Hurault de Ligny B; Buchler M; Rerolle JP; Thierry A; Moulin B; Subra JF; Deteix P; Le Pogamp P; Finzi L; Etienne I
    Am J Transplant; 2012 Jul; 12(7):1801-10. PubMed ID: 22486815
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sirolimus in transplantation.
    Stepkowski SM; Tian L; Wang ME; Qu X; Napoli K; Kahan BD
    Arch Immunol Ther Exp (Warsz); 1997; 45(5-6):383-90. PubMed ID: 9437494
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Spanish validation of the "kidney transplant questionnaire": a useful instrument for assessing health related quality of life in kidney transplant patients.
    Rebollo P; Ortega F; Ortega T; Valdés C; García-Mendoza M; Gómez E
    Health Qual Life Outcomes; 2003 Oct; 1():56. PubMed ID: 14613566
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of low dose cyclosporine and sirolimus on hepatic drug metabolism in the rat1.
    Bai S; Brunner LJ; Stepkowski SM; Napoli KL; Kahan BD
    Transplantation; 2001 Jun; 71(11):1585-92. PubMed ID: 11435969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.